JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares
ZJYL
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$3.32 – $3.63
Volume20,091
Market cap$267M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for ZJYL.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for ZJYL.
Recent news
Company coverage with links to the original publishers.
Jin Medical International Ltd. (NASDAQ: ZJYL), a provider of rehabilitation medical equipment, announced a 1-for-20 share combination effective March 16, 2026. The stock consolidation will reduce Class A shares from 136.5 million to 6.8 million and Class B shares from 20 million to 1 million. The company states this is a proactive measure to maintain Nasdaq compliance and strengthen its long-term capital structure.
Jin Medical International Ltd. (NASDAQ: ZJYL), a leading provider of rehabilitation medical equipment in China, announced that its management team will host a fireside chat on February 1, 2026, to discuss strategic priorities and capital structure considerations. The company stated it maintains a strong liquidity position and is actively evaluating strategic options to enhance its competitive position.
Jin Medical International Ltd. has launched production at its new Plant No. 3 in Chuzhou, Anhui, China, with an annual production capacity of 200,000 units and advanced robotic manufacturing capabilities targeting global rehabilitation equipment markets.
JIN MEDICAL INTERNATIONAL LTD. (JinMed) announced the initiation of construction of a new manufacturing facility in Chuzhou, China. The new facility will focus on producing wheelchairs, electric wheelchairs, and other healthcare products, strengthening JinMed's leadership in the assistive technology industry.
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.
Bitdeer Technologies Group shares jumped 10.2% to $7.45 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
BitFuFu Inc. (NASDAQ: FUFU) shares jumped 107% to $13.20 amid volatility following the company's recent business combination with Arisz Acquisition Corp and listing on the Nasdaq.
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) climbed 89% to $5.31 after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.
Renalytix Plc (NASDAQ: RNLX) gained 52.8% to $1.5890 after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.
Phunware, Inc. (NASDAQ: PHUN) climbed 42.7% to $10.11. Phunware is expected to report fourth-quarter results on March 12, 2024.
Ainos, Inc. (NASDAQ: AIMD) gained 39.4% to $1.4650.
Jaguar Health, Inc. (NASDAQ: JAGX) shares climbed 38.2% to $0.1223 after surging 50% on Friday.
Cardiff Oncology, Inc. (NASDAQ: CRDF) rose 31.6% to $3.83 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.
The E.W. Scripps Company (NASDAQ: SSP) gained 31.3% to $4.94. E.W. Scripps Director Charles L. Barmonde acquired a total of 10,500 shares an average price of $4.28.
Helius Medical Technologies, Inc. (NASDAQ: HSDT) climbed 30% to $5.91. Helius Medical Technologies announced it secured HCPCS codes for portable neuromodulation stimulator mouthpiece and controller.
Kineta, Inc. (NASDAQ: KA) gained 27% to $1.14. Kineta recently announced a restructuring and the exploration of strategic alternatives.
BigBear.ai Holdings, Inc. (NYSE: BBAI) rose 25% to $4.3472.
Critical Metals Corp. (NASDAQ: CRML) gained 24.4% to $12.44.
Ocean Biomedical, Inc. (NASDAQ: OCEA) gained 22% to $2.44.
Reliance Global Group, Inc. (NASDAQ: RELI) rose 21.7% to $0.6299 after gaining 11% on Friday.
Akero Therapeutics, Inc. (NASDAQ: AKRO) ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.